Back to Results
First PageMeta Content
Anticoagulants / Ketones / Bristol-Myers Squibb / Hematology / Dabigatran / Warfarin / Rivaroxaban / Apixaban / Stroke / Chemistry / Organic chemistry / Propionic acids


Safety Alert Novel Oral Anticoagulants (NOACs) Issue Apixaban (Eliquis®), dabigatran (Pradaxa®) and rivaroxaban (Xarelto®) are anticoagulants licensed in varying doses in adults for prevention and treatment of venous
Add to Reading List

Document Date: 2015-05-07 16:55:49

Open Document

File Size: 111,49 KB

Share Result on Facebook
UPDATE